Based
AUSTIN, TEXAS
AUSTIN, TEXAS
Industry group
Biotechnology
Biotechnology
Filings
3
3
Raised (new offerings)
$12.05M
$12.05M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-07-02 | Amendment first sale 2025-09-12 | $2.65M | $4.90M | SEC filing |
| 2025-10-08 | New offering first sale 2025-09-30 | $9.87M | $10.52M | SEC filing |
| 2025-09-23 | New offering first sale 2025-09-12 | $2.18M | $2.18M | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Mati Therapeutics Inc.'s own filings with the SEC. The people those filings name are on the team page.